Medherant, a University of Warwick spin-out company and innovator in transdermal drug delivery, has announced positive results from its initial Phase 1 clinical trial of its testosterone patch for post-menopausal women. The study, conducted at Hammersmith Medicines Research (HMR) in London, demonstr
Biotech company Cyclana Bio has announced the close of a 5 million GBP pre-seed funding round, co-led by NfX and Eka VC, and including Cocoa VC, Wilbe, and Angel investors. The investment will enable Cyclana Bio to develop functional disease models and its platform, which its says is dedicated to re
Plexāā, a MedTech company focused on improving surgical outcomes through devices and digital products, has announced the U.S. launch of its BLOOM43 platform, a combination of a wearable preconditioning medical device and app developed to prepare patients for breast surgery. The BLOOM43 device, worn
Aspivix, a FemTech company specialising in the modernisation of gynaecological care, has announced the official launch of its breakthrough device, carevix, now available to healthcare professionals in Southern California and New York State. The company claims the device delivers an innovative, less
Tasso, a specialist in patient-centric blood collection, and SheMed, a UK-based women’s healthcare company, have teamed up to deliver safer, more personalised weight loss treatments through convenient at-home diagnostics. SheMed’s patient-friendly testing program, which integrates the Tasso+ blood c
Cartherics, a biotech company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, has announced the granting of a patent for ‘Method for Providing Immune Cells with Enhanced Function’ by the Chinese Patent O
Daye has just launched a comprehensive at-home hormone testing service across the UK, and Med-Tech Insights spoke to Valentina Milanova, founder & CEO of Daye to find out more. 1. What specific hormones does the at-home test measure, and how do these results help identify conditions like PCOS?Daye’s
Boston Scientific Corporation has announced data from a recent national survey of 2,000 U.S. women between the ages of 30 and 65, which examined women’s motivations, frustrations and approaches related to weight loss. The release of the data coincides with the launch of Boston Scientific’s Endura We
Europa Road is playing a vital role in global healthcare by delivering time-critical medical testing kits, which are then distributed to clinics across Asia, Africa, Europe, and the UK. As part of one of Britain’s largest independent logistics providers, Europa Worldwide Group, Europa Road is suppo
UK based Medical Technology company Forte Medical is launching a national survey of women in the UK to ascertain their exposure to urine sampling retests and immediate empirical broad spectrum prescribing, triggered by traditional methods of specimen collection for Urinary Tract Infection and prenat
Women’s cancer screening is life-saving, yet the services that support it and the workforce and technologies behind them, are facing growing pressure. Hologic brought together a Women’s Cancer Screening Taskforce of expert clinicians to examine how advanced technologies alongside workforce investmen
After AbbVie announced the marketing authorisation from MHRA for ELAHERE, Med-Tech Insights spoke to the company to find out more. When do you anticipate mirvetuximab soravtansine will be available to eligible patients? Mirvetuximab soravtansine is now licensed as a monotherapy in the UK for the tre
